Integrin α2: mode of regulation and functioning in the metastatic cancer cascade

Integrin α2β1, a major collagen-binding receptor, functions as a key mediator of cell-extracellular matrix (ECM) communication, mechanosensing, and adhesion-dependent signaling. As a core molecular switch in cancer biology, integrin α2 profoundly influences the metastatic cascade-from local invasion, intravasation, survival in circulation, and pre-metastatic niche formation to dormancy and colonization. Although extensive studies indicate that integrin α2β1 regulates tumor proliferation, migration, ECM remodeling, angiogenesis, and immune modulation, its mechanochemical activation mechanisms and context-dependent functions across different stages of metastasis remain incompletely defined.

This review systematically summarizes the structural characteristics, activation mechanisms, regulatory networks, and functional roles of integrin α2β1 in the cancer metastatic cascade. We first describe the domain architecture of integrin α2, emphasizing the structural determinants underlying ligand specificity and metal ion-dependent adhesion. We then outline multi-level regulatory mechanisms that drive variable integrin α2 expression across tumor types. The dual biochemical and mechanical modes of integrin α2β1 activation are discussed, with emphasis on nanocluster formation, focal adhesion maturation, force-dependent conformational changes, and key downstream signaling pathways. We further dissect the stage-specific contributions of integrin α2β1 at each stage of metastasis, including its contributions to epithelial-mesenchymal transition, matrix metalloproteinase - mediated ECM degradation, vascular remodeling, circulating tumor cell survival, immune evasion, pre-metastatic niche formation, tumor dormancy, and organotropic colonization. Finally, we review current progress in integrin α2-targeted therapies-including small-molecule inhibitors, monoclonal antibodies, natural compounds, and nanomedicine-based delivery systems-and discuss future directions that leverage mechanobiology, integrin-targeted biomaterials, and computational drug design.

Integrin α2β1 is a central mechanochemical regulator of the metastatic cascade, coordinating tumor cell responses to extracellular and intracellular cues. Its functions span critical metastatic processes, making integrin α2 and its downstream pathways promising therapeutic targets. Continued advances in mechanobiology and multi-omics technologies will be essential to refine integrin-centered strategies and improve interventions against metastatic cancer.